Neural Therapeutics Inc.
Neural Therapeutics Inc.
Neural Therapeutics is an ethnobotanical drug discovery company, focusing on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. The Company’s innovative approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract, enhancing safety and scalability while maintaining therapeutic efficacy.
Neural Therapeutics Inc. (NURL)
Neural Therapeutics Inc. (NURL)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| RBC Capital Markets | 50,000 | 0.025 | 0.03 | 19,000 | Anonymous |
| National Bank Financial Inc. | 14,000 | 0.025 | 0.03 | 30,000 | Questrade Inc. |
| RBC Capital Markets | 150,000 | 0.025 | 0.035 | 67,000 | Anonymous |
| RBC Capital Markets | 150,000 | 0.025 | 0.035 | 1,000 | BMO Nesbitt Burns Inc. |
| Anonymous | 1,000 | 0.025 | 0.035 | 99,000 | RBC Capital Markets |
| TD Securities Inc. | 1,000 | 0.025 | 0.05 | 50,000 | Anonymous |
| RBC Capital Markets | 25,000 | 0.025 | 0.14 | 7,000 | TD Securities Inc. |
| TD Securities Inc. | 1,000 | 0.025 | 1.00 | 5,000 | Scotia Capital Inc. |
| TD Securities Inc. | 1,000 | 0.025 | 0.00 | 0 | |
| TD Securities Inc. | 1,000 | 0.025 | 0.00 | 0 |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 10 | 394,000 | 0.025 | 0.03 | 49,000 | 2 |
| 6 | 138,000 | 0.02 | 0.035 | 167,000 | 3 |
| 3 | 259,000 | 0.015 | 0.05 | 50,000 | 1 |
| 2 | 3,040,000 | 0.01 | 0.14 | 7,000 | 1 |
| 1 | 200,000 | 0.005 | 1.00 | 5,000 | 1 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Mar 28, 19:21 | 0.03 | 0.00 | 1,000 | Anonymous | Anonymous | CSE |
| Mar 28, 16:09 | 0.03 | 0.00 | 2,000 | National Bank Financial Inc. | Anonymous | CSE |
| Mar 28, 15:35 | 0.03 | 0.00 | 13,000 | TD Securities Inc. | Anonymous | CSE |
| Mar 28, 13:38 | 0.03 | 0.00 | 2,000 | National Bank Financial Inc. | Anonymous | CSE |
| Mar 28, 13:34 | 0.03 | 0.00 | 4,000 | Scotia Capital Inc. | Anonymous | CSE |
Company Info
SEDAR Information
Company Info
Capitalization
Company Officers
News Releases
Bulletins
2025-0315 - New Listing - Neural Therapeutics Inc. (NURL)
le 13 mars/March 2025
The common shares of Neural Therapeutics Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
